Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation

被引：0
|
作者：
A M Carella
机构：
[1] Azienda Ospedaliera Universitaria San Martino,Division of Hematology
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1090 / 1091
页数：1
相关论文
共 50 条
  • [1] Interferon-α is able to maintain complete molecular remission induced by imatinib after its discontinuation
    Carella, A. M.
    LEUKEMIA, 2008, 22 (05) : 1090 - 1091
  • [2] Interferon-alpha (IFN-a) given alone to CML patients with undetectable disease after imatinib (IM) is able to maintain their complete molecular remission after IM discontinuation
    Carella, A. M.
    BLOOD, 2007, 110 (11) : 210B - 210B
  • [3] Interferon-Alpha (IFN-a) Is Able To Maintain Complete Molecular Response (CMR) In Chronic Myeloid Leukemia (CML) Patients Who Maintain Undetectable disease After Imatinib (IM) Discontinuation
    Carella, Angelo Michele
    Beltrami, Germana
    Ghiggi, Chiara
    BLOOD, 2013, 122 (21)
  • [4] Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia
    Henandez-Boluda, Juan-Carlos
    Collado, Maria
    Roda, Desamparados
    Amat, Paula
    Tormo, Mar
    Marugan, Isabel
    LEUKEMIA RESEARCH, 2009, 33 (04) : 589 - 592
  • [5] Sustained Complete Molecular Remission after Imatinib Discontinuation in Children with Chronic Myeloid Leukemia
    Moser, Olga
    Krumbholz, Manuela
    Thiede, Christian
    Tauer, Josephine T.
    Janz, Indra
    Lauten, Melchior
    Dilloo, Dagmar
    Metzler, Markus
    Suttorp, Meinolf
    PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2080 - 2082
  • [6] Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph plus CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon
    Breccia, M.
    Diverio, D.
    Pane, F.
    Nanni, M.
    Russo, E.
    Biondo, F.
    Frustaci, A.
    Gentilini, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2006, 30 (12) : 1577 - 1579
  • [7] Leukemic clone does not disappear in patients who remain in complete molecular remission after discontinuation of imatinib
    Costello, Regis
    HEMATOLOGIE, 2010, 16 (06): : 398 - 399
  • [8] Persistence of complete molecular remission in chronic myeloid leukemia after imatinib discontinuation: Interim analysis of the STIM trial
    Mahon, F.
    Rea, D.
    Guilhot, F.
    Legros, L.
    Guilhot, J.
    Aton, E.
    Dulucq, S.
    Reiffers, J.
    Rousselot, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Imatinib discontinuation: realistic for patients with chronic myeloid leukaemia achieving complete molecular remission?
    Stagno, Fabio
    Vigneri, Paolo
    Di Raimondo, Francesco
    LANCET ONCOLOGY, 2011, 12 (02): : 118 - 118
  • [10] Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha
    Murphy, Philip T.
    McPherson, Suzanne
    Langabeer, Stephen E.
    ANNALS OF HEMATOLOGY, 2011, 90 (02) : 233 - 234
12345